Medicalgorithmics is entering the field of cardiac surgery robotics
Medicalgorithmics, a Warsaw Stock Exchange-listed developer of innovative technologies in the field of cardiology, is taking a significant step towards expanding its therapeutic capabilities in cardiac surgery. The company has signed a letter of intent with the Prof. Zbigniew Religa Foundation for the Development of Cardiac Surgery in Zabrze and Biofund Capital Management, under which it is negotiating the terms of cooperation on the development of a proprietary surgical robot. The project aims to develop a minimally invasive robotic system to assist doctors in performing procedures to treat structural heart defects.
Once launched, the system has the potential to become a breakthrough step for Medicalgorithmics towards building a comprehensive diagnostic and therapeutic model — from advanced analysis and diagnosis of heart diseases and defects to technologies supporting their effective, precise treatment.